Current Role and Future Perspectives of Radioiodinated MIBG in the Evaluation of Dementia with Lewy Bodies

Author(s): Giorgio Treglia, Luca Ceriani, Luca Giovanella

Journal Name: Current Radiopharmaceuticals

Volume 7 , Issue 1 , 2014

Become EABM
Become Reviewer


Dementia with Lewy bodies (DLB) is the second most common cause of degenerative dementia after Alzheimer’s disease (AD). To improve the diagnosis of DLB, the latest diagnostic criteria incorporate findings from neuroimaging studies including sympathetic innervation imaging with iodine-123-metaiodobenzylguanidine (MIBG). According to these criteria a decreased MIBG myocardial uptake is an important finding supporting a clinical diagnosis of DLB. In this review the state of art and future perspectives of sympathetic innervation imaging by using MIBG in the diagnosis of DLB are discussed.

Keywords: Dementia with Lewy bodies, dementia, innervation imaging, metaiodobenzylguanidine, MIBG.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 22 August, 2014
Page: [75 - 78]
Pages: 4
DOI: 10.2174/1874471007666140314094323

Article Metrics

PDF: 36